• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Overcoming institutional and community resistance to a tardive dyskinesia management program.

作者信息

Wolf M E, Brown P

出版信息

Hosp Community Psychiatry. 1987 Jan;38(1):65-8. doi: 10.1176/ps.38.1.65.

DOI:10.1176/ps.38.1.65
PMID:2879787
Abstract

A growing body of research has examined psychiatry's previously hesitant response to the problem of tardive dyskinesia, but little has been said about resistance among institutions and communities to managing tardive dyskinesia. This paper describes how staff of a tardive dyskinesia management program overcame such resistance in both an inpatient and an outpatient setting and implemented tardive dyskinesia guidelines promulgated by an American Psychiatric Association task force in 1979. Through educational and liaison activities, the program staff overcame the fears of nurses and community sponsors of outpatients about reducing or withdrawing patients' neuroleptic medication. Implementation of the program required strong support from the hospital administration and an increase in communication between the various services and outpatient programs treating patients with tardive dyskinesia.

摘要

相似文献

1
Overcoming institutional and community resistance to a tardive dyskinesia management program.
Hosp Community Psychiatry. 1987 Jan;38(1):65-8. doi: 10.1176/ps.38.1.65.
2
Overcoming resistance to talking to patients about tardive dyskinesia.
Hosp Community Psychiatry. 1985 Mar;36(3):283-7. doi: 10.1176/ps.36.3.283.
3
Prevention and management of tardive dyskinesia.迟发性运动障碍的预防与管理。
J Clin Psychiatry. 1985 Apr;46(4 Pt 2):14-8.
4
Tardive dyskinesia and institutional practice: current issues and guidelines.迟发性运动障碍与机构实践:当前问题与指南
Hosp Community Psychiatry. 1980 Apr;31(4):239-44. doi: 10.1176/ps.31.4.239.
5
Psychopharmacists' role in neuroleptic therapy. A pharmaceutical care approach.精神药理学家在抗精神病药物治疗中的作用。一种药学服务模式。
J Pharm Technol. 1994 Jul-Aug;10(4):164-8. doi: 10.1177/875512259401000407.
6
Clinical and epidemiologic aspects of tardive dyskinesia.迟发性运动障碍的临床与流行病学特征
J Clin Psychiatry. 1985 Apr;46(4 Pt 2):8-13.
7
[Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
Tijdschr Psychiatr. 2007;49(1):37-41.
8
Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
Geriatrics. 1979 Jul;34(7):59-61, 66.
9
Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.减少和/或停用抗精神病药物以及将抗精神病药物作为迟发性运动障碍的特定治疗方法。
Cochrane Database Syst Rev. 2000(2):CD000459. doi: 10.1002/14651858.CD000459.
10
CMHC practices related to tardive dyskinesia screening and informed consent for neuroleptic drugs.与迟发性运动障碍筛查及抗精神病药物知情同意相关的社区精神卫生中心实践。
Hosp Community Psychiatry. 1994 Apr;45(4):343-6. doi: 10.1176/ps.45.4.343.